Does ELOTUZUMAB Cause Nasopharyngitis? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Nasopharyngitis have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.6% of all adverse event reports for ELOTUZUMAB.
21
Reports of Nasopharyngitis with ELOTUZUMAB
0.6%
of all ELOTUZUMAB reports
4
Deaths
6
Hospitalizations
How Dangerous Is Nasopharyngitis From ELOTUZUMAB?
Of the 21 reports, 4 (19.0%) resulted in death, 6 (28.6%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for ELOTUZUMAB.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which ELOTUZUMAB Alternatives Have Lower Nasopharyngitis Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE